DE2937698A1
(de)
*
|
1979-09-18 |
1981-04-02 |
A. Nattermann & Cie GmbH, 5000 Köln |
N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
|
DK373383A
(da)
*
|
1982-08-20 |
1984-02-21 |
Midit |
Fremgangsmaade til fremstilling af omega-aminosyrederivater
|
US4798687A
(en)
*
|
1987-02-06 |
1989-01-17 |
Pennwalt Corporation |
2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
|
US4904681A
(en)
*
|
1987-12-01 |
1990-02-27 |
G. D. Searle & Co. |
D-cycloserine and its prodrugs as cognitive enhancers
|
US4891058A
(en)
*
|
1988-07-18 |
1990-01-02 |
Ici Americas Inc. |
1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
|
US5278191A
(en)
*
|
1988-08-31 |
1994-01-11 |
G. D. Searle & Co. |
Diphenylmethylaminoacetamide derivatives as anti-convulsants
|
US5288905A
(en)
*
|
1988-10-07 |
1994-02-22 |
G. D. Searle & Co. |
Glycyl urea derivatives as anti-convulsants
|
US4944796A
(en)
*
|
1988-11-14 |
1990-07-31 |
Ici Americas Inc. |
Certain 2-(disubstituted amino) acetanilide herbicides
|
DE3915755A1
(de)
*
|
1989-05-13 |
1990-11-29 |
Bayer Ag |
Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
|
IL94466A
(en)
*
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
US5075337A
(en)
*
|
1989-07-26 |
1991-12-24 |
G. D. Searle & Co. |
Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
|
US5153226A
(en)
*
|
1989-08-31 |
1992-10-06 |
Warner-Lambert Company |
Acat inhibitors for treating hypocholesterolemia
|
DE4102042A1
(de)
*
|
1991-01-24 |
1992-07-30 |
Bayer Ag |
Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
|
US5141960A
(en)
*
|
1991-06-25 |
1992-08-25 |
G. D. Searle & Co. |
Tricyclic glycinamide derivatives as anti-convulsants
|
GB9306899D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
|
GB9306886D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
|
US5585358A
(en)
*
|
1993-07-06 |
1996-12-17 |
Yissum Research Development Corporation Of The Hebrew University Of Jerusalem |
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
|
IL127244A
(en)
*
|
1996-05-31 |
2005-11-20 |
Allelix Neuroscience Inc |
Substituted amines, methods of their preparation and pharmaceutical compositions containing them
|
US6191165B1
(en)
*
|
1996-05-31 |
2001-02-20 |
Allelix Neuroscience Inc. |
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
IT1283489B1
(it)
*
|
1996-07-23 |
1998-04-21 |
Chiesi Farma Spa |
Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
WO1999048858A2
(fr)
*
|
1998-03-26 |
1999-09-30 |
University Of Saskatchewan Technologies Inc. |
Acides amino phosphoniques et amino carboxyliques aliphatiques, amino nitriles et amino tetrazoles utilises en tant qu'agents de retablissement de fonctions cellulaires
|
US6984754B1
(en)
|
1998-03-26 |
2006-01-10 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
|
US6346547B1
(en)
*
|
1999-02-08 |
2002-02-12 |
Checkpoint, Genetics, Inc. |
N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
|
CN1251758C
(zh)
|
2000-07-21 |
2006-04-19 |
特瓦制药工业有限公司 |
丙戊酸和2-丙基戊烯酸酰胺的衍生物在制备治疗双极情感障碍症躁狂病药物中的用途
|
KR100851955B1
(ko)
*
|
2000-08-17 |
2008-08-12 |
이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 |
통증 및/또는 두통 장애를 치료하거나 방지하기 위한 벨프로익산 아미드 및 2-벨프로에닉산 아미드 유도체의 용도
|
DE60134337D1
(de)
*
|
2000-11-21 |
2008-07-17 |
Ucb Pharma Sa |
N-alkylierte gaba verbindungen, verfahren zu deren
|
NZ527695A
(en)
|
2001-02-16 |
2005-05-27 |
Allelix Neuroscience Inc |
GlyT-1 inhibitors
|
US20030035784A1
(en)
*
|
2001-03-05 |
2003-02-20 |
Kao Corporation |
Hair cosmetic, aminocarboxylic acid amide and method for producing the same
|
PT1423168E
(pt)
|
2001-09-03 |
2006-05-31 |
Newron Pharm Spa |
Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
|
EP1438956A1
(fr)
*
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Dérivés alpha-aminoamides en tant qu'agents antimigraine
|
ES2347581T3
(es)
*
|
2004-09-10 |
2010-11-02 |
Newron Pharmaceuticals S.P.A. |
Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio.
|
EP1791932A1
(fr)
*
|
2004-09-13 |
2007-06-06 |
Ciba Specialty Chemicals Holding Inc. |
Additifs d'alkylaminoacetamide pour lubrifiants
|
FR2896991A1
(fr)
*
|
2006-02-03 |
2007-08-10 |
Inst Nat Sante Rech Med |
Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
|
CN102351733B
(zh)
*
|
2011-07-21 |
2014-03-19 |
凯莱英医药化学(阜新)技术有限公司 |
一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
|
SI3766916T1
(sl)
|
2014-06-25 |
2023-01-31 |
Acuitas Therapeutics Inc. |
Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin
|
JP6053724B2
(ja)
*
|
2014-06-26 |
2016-12-27 |
国立大学法人九州大学 |
イオン交換樹脂及び金属の吸着分離方法
|
WO2017004143A1
(fr)
|
2015-06-29 |
2017-01-05 |
Acuitas Therapeutics Inc. |
Formulations de lipides et de nanoparticules de lipides pour l'administration d'acides nucléiques
|
CN113636947A
(zh)
|
2015-10-28 |
2021-11-12 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
CN106187829B
(zh)
*
|
2016-07-29 |
2017-12-15 |
万华化学集团股份有限公司 |
一种制备乙二胺基乙磺酸盐的方法
|
US11357856B2
(en)
|
2017-04-13 |
2022-06-14 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
CN110799492B
(zh)
|
2017-04-28 |
2023-06-27 |
爱康泰生治疗公司 |
用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂
|
EP3668833A1
(fr)
|
2017-08-16 |
2020-06-24 |
Acuitas Therapeutics, Inc. |
Lipides destinés à être utilisés dans des formulations nanoparticulaires lipidiques
|
WO2019036028A1
(fr)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipides destinés à être utilisés dans des formulations nanoparticulaires lipidiques
|
CA3073018A1
(fr)
*
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipides destines a etre utilises dans des formulations de nanoparticules lipidiques
|
WO2019036030A1
(fr)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques
|
KR101953366B1
(ko)
|
2018-12-26 |
2019-02-28 |
정종문 |
침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
|
EP3908568A1
(fr)
|
2019-01-11 |
2021-11-17 |
Acuitas Therapeutics, Inc. |
Lipides pour l'administration de nanoparticules lipidiques d'agents actifs
|
USD926577S1
(en)
|
2019-09-23 |
2021-08-03 |
Verdant Ventures |
Tamper-resistant lid assembly
|
US11326923B2
(en)
|
2019-10-08 |
2022-05-10 |
Verdant Ventures |
Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
|